(Q32061134)

6 July 2017

1 reference

title

Thyroid eye disease in children and adolescents--new therapeutic approaches (English)

1 reference

6 July 2017

1 reference

1 reference

Krassas GE

1

1 reference

6 July 2017

publication date

1 January 2001

1 reference

Journal of Pediatric Endocrinology and Metabolism

6 July 2017

published in

1 reference

6 July 2017

volume

14

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

97-100

1 reference

Concurrence of Grave's disease and Hashimoto's thyroiditis

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Hyperthyroidism attributable to a hyperfunctioning thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

CHILDHOOD THYROTOXICOSIS: A LONG-TERM PERSPECTIVE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Ocular manifestations in children and adolescents with thyrotoxicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Special features of Graves' disease in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Treatment of Graves' disease and the course of ophthalmopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Somatostatin analogues in the treatment of thyroid eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Effects of octreotide treatment on Graves' ophthalmopathy and circulating sICAM-1 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

Lanreotide in the treatment of patients with thyroid eye disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2001.14.1.97

10.1515/JPEM.2001.14.1.97

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference